trial

Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis

NCTId NCT03409393
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 27 (actual)
Sponsored by Rigshospitalet, Denmark
Primary completion 2018-06-20
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
27 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2018-01-22
Primary completion
2018-06-20
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
The COPUS intervention

Sponsors

Rigshospitalet, DenmarkLead Sponsor
University of CopenhagenCollaborator
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalCollaborator

Investigators

2
Julie A Kreyenbuhl, Pharm.D PhDPrincipal Investigator
Helle Schnor, Ph.D.Study Director

Sites

1 total
Brøndby, Denmark

Facts & assertions

4 sourced
Enrollment
27
Phase
NA
Primary Completion Date
2018-06-20
Status
COMPLETED
relationships
The graph out of here
drug
The COPUS intervention
drug
lead_sponsor
Rigshospitalet, Denmark
company
collaborator
University of Copenhagen
company
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
company
indication
Psychotic Disorders
indication
Schizotypal Personality Disorder
indication
Schizotypal Disorder
indication
investigator
Julie A Kreyenbuhl, Pharm.D PhD
person
Helle Schnor, Ph.D.
person